Los desarrolladores de Apache, acargo del popular IDE de desarrollo de «NetBeans» dieron a conocer la reciente liberacion de ...
April 24 (Reuters) - German biotech company CureVac sued Moderna (MRNA.O), opens new tab in Delaware federal court on Friday, alleging that Moderna's COVID-19 vaccine Spikevax infringed CureVac ...
Moderna’s mRNA-based combination vaccine against both flu and COVID-19 has gotten the green light in Europe—but it continues to be shelved in the US, where it was developed. This week, the European ...
“El romance de Genji” nació en una corte aislada de Japón y hoy es considerada por especialistas como la primera novela psicológica del mundo. The Tale of Genji, la obra escrita por una mujer japonesa ...
En este video recorremos el centro de Rotterdam, mostrando su impresionante skyline, arquitectura innovadora y la vida urbana cotidiana. Descubre el diseño único, los espacios abiertos y el ambiente ...
Moderna CEO Stéphane Bancel’s total compensation remained remarkably stable last year at $19.9 million, even as the vaccines company navigated a “challenging regulatory and business environment.” ...
Agrega Yahoo como fuente de noticias preferida para ver más de nuestras historias en Google. Sánchez envía una fragata a la zona de conflicto tras proclamar el lema “No a la guerra” - Créditos: @JIM ...
Moderna MRNA.O has agreed to pay Genevant Sciences, a subsidiary of Roivant Sciences ROIV.O, and Arbutus Biopharma ABUS.O up to $2.25 billion to settle a long-running legal fight over the technology ...
Moderna MRNA0.74%increase; green up pointing triangle will pay $950 million to settle patent litigation by Arbutus Biopharma and Genevant Sciences GmbH. The vaccine maker said Tuesday that, as part of ...
Once envisioned as a bridge between Java and JavaScript, the Detroit project never got off the ground. Now, there are efforts at reviving it, adding a Python engine to the mix. Intended to enable ...
The Food and Drug Administration reversed an earlier decision to not review Moderna's flu vaccine and will evaluate the company's modified application for a potential approval, Moderna said on Feb. 18 ...
WASHINGTON (AP) — The Food and Drug Administration will consider whether to approve Moderna's new flu vaccine after all, resolving a dispute that had blocked the company's application for the first-of ...